224 related articles for article (PubMed ID: 10686032)
21. Enhanced neutralization of human respiratory syncytial virus by mixtures of monoclonal antibodies to the attachment (G) glycoprotein.
Martínez I; Melero JA
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2215-20. PubMed ID: 9747731
[TBL] [Abstract][Full Text] [Related]
22. Mutations of respiratory syncytial virus attachment glycoprotein G associated with resistance to neutralization by primate polyclonal antibodies.
Sullender WM; Edwards KG
Virology; 1999 Nov; 264(1):230-6. PubMed ID: 10544149
[TBL] [Abstract][Full Text] [Related]
23. Human monoclonal antibodies isolated from spontaneous Epstein-Barr virus-transformed tumors of Hu-SPL-SCID mice and specific for fusion protein display broad neutralizing activity toward respiratory syncytial virus.
Chamat S; Walsh EE; Anderson D; Osta M; Awaraji C; Pan LZ; Ochi J; Shuey S; Brams P
J Infect Dis; 1999 Aug; 180(2):268-77. PubMed ID: 10395839
[TBL] [Abstract][Full Text] [Related]
24. Antigenic and genetic variation in human respiratory syncytial virus.
Wertz GW; Moudy RM
Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S19-24. PubMed ID: 14730266
[TBL] [Abstract][Full Text] [Related]
25. Prophylaxis with respiratory syncytial virus F-specific humanized monoclonal antibody delays and moderately suppresses the native antibody response but does not impair immunity to late rechallenge.
Fisher RG; Johnson JE; Dillon SB; Parker RA; Graham BS
J Infect Dis; 1999 Sep; 180(3):708-13. PubMed ID: 10438358
[TBL] [Abstract][Full Text] [Related]
26. Serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines coformulated with natural fusion and attachment proteins of respiratory syncytial virus.
Hancock GE; Smith JD; Heers KM
J Infect Dis; 2000 May; 181(5):1768-71. PubMed ID: 10823781
[TBL] [Abstract][Full Text] [Related]
27. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
[TBL] [Abstract][Full Text] [Related]
28. Linear antigenic and immunogenic regions of the respiratory syncytial virus P protein.
Leonov SV; Utter G; Waris M; Norrby E
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1353-9. PubMed ID: 8207401
[TBL] [Abstract][Full Text] [Related]
29. Purification of a recombinant human respiratory syncytial virus chimeric glycoprotein using reversed-phase chromatography and protein refolding in guanidine hydrochloride.
Wells PA; Garlick RL; Lyle SB; Tuls JL; Poorman RA; Brideau RJ; Wathen MW
Protein Expr Purif; 1994 Aug; 5(4):391-401. PubMed ID: 7950387
[TBL] [Abstract][Full Text] [Related]
30. Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis.
Harcourt JL; Karron RA; Tripp RA
J Infect Dis; 2004 Dec; 190(11):1936-40. PubMed ID: 15529257
[TBL] [Abstract][Full Text] [Related]
31. Analysis of linear epitopes recognised by the primary human antibody response to a variable region of the attachment (G) protein of respiratory syncytial virus.
Cane PA
J Med Virol; 1997 Apr; 51(4):297-304. PubMed ID: 9093944
[TBL] [Abstract][Full Text] [Related]
32. Comparison of human respiratory syncytial virus A2 and 8/60 fusion glycoprotein gene sequences and mapping of sub-group specific antibody epitopes.
Connor AL; Bevitt DJ; Toms GL
J Med Virol; 2001 Feb; 63(2):168-77. PubMed ID: 11170054
[TBL] [Abstract][Full Text] [Related]
33. Preparation of a respiratory syncytial virus human reference serum for use in the quantitation of neutralization antibody.
Yang DP; Zielinska E; Quiroz J; Madore D; Rappaport R
Biologicals; 2007 Jun; 35(3):183-7. PubMed ID: 17241789
[TBL] [Abstract][Full Text] [Related]
34. Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo.
Crowe JE; Gilmour PS; Murphy BR; Chanock RM; Duan L; Pomerantz RJ; Pilkington GR
J Infect Dis; 1998 Apr; 177(4):1073-6. PubMed ID: 9534985
[TBL] [Abstract][Full Text] [Related]
35. The response of infants with bronchiolitis to the proteins of respiratory syncytial virus.
Levine S; Dajani A; Klaiber-Franco R
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1229-39. PubMed ID: 3385405
[TBL] [Abstract][Full Text] [Related]
36. Co-immunization of BALB/c mice with recombinant immunogens containing G protein fragment and chimeric CTL epitope of respiratory syncytial virus induces enhanced cellular immunity and high level of antibody response.
Fan CF; Mei XG
Vaccine; 2005 Aug; 23(35):4453-61. PubMed ID: 15935522
[TBL] [Abstract][Full Text] [Related]
37. Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins.
Fuentes S; Coyle EM; Beeler J; Golding H; Khurana S
PLoS Pathog; 2016 Apr; 12(4):e1005554. PubMed ID: 27100289
[TBL] [Abstract][Full Text] [Related]
38. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.
Arbiza J; Taylor G; López JA; Furze J; Wyld S; Whyte P; Stott EJ; Wertz G; Sullender W; Trudel M
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2225-34. PubMed ID: 1383404
[TBL] [Abstract][Full Text] [Related]
39. Linear antigenic and immunogenic regions of human respiratory syncytial virus N protein.
Leonov SV; Waris M; Norrby E
J Gen Virol; 1995 Feb; 76 ( Pt 2)():357-64. PubMed ID: 7531217
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of anti-human respiratory syncytial virus antibodies over three consecutive years in a healthy adult population.
Chala SR; García-Barreno B; Melero JA; Palomo C
J Med Virol; 2003 Oct; 71(2):298-304. PubMed ID: 12938206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
